mellowsong
01-30-09, 03:43 PM
Steve Stiles
January 29, 2009 (St Louis, Missouri)- Generic drug maker ETHEX Corp, a subsidiary of KV Pharmaceutical, has suspended the manufacture, shipping, and sale of more than 100 products, nearly its entire product line, "as a precautionary measure" following recent recalls of certain specific lots of some of the products, the parent company has announced [1,2].
On the list of suspended drugs are preparations of amlodipine, diltiazem, isosorbide mononitrate, nitroglycerin, and propafenone along with potassium supplements.
"These actions are being taken in cooperation with the previously announced inspection by the FDA of the company’s operations and inventory, which began in December," the company stated in a January 26, 2009 press release.
The earlier recalls had followed the discovery of defects in some product lots, "including oversized tablets delivering higher-than-labeled doses," KV said. It hopes to resume the manufacture and sale of the products after it "reviews its manufacturing and packaging processes."
ETHEX Corp. ETHEX Corporation issues nationwide voluntary recall of products [press release]. January 28, 2009. Available at: http://www.ethex.com/news/pressRelease012809.aspx (http://www.ethex.com/news/pressRelease012809.aspx).
KV Pharmaceutical. KV Pharmaceutical suspends product manufacturing, shipping [press release]. January 26, 2009. Available at: http://www.kvpharma.com/news_center_article.aspx?articleid=278 (http://www.kvpharma.com/news_center_article.aspx?articleid=278).The complete contents of Heartwire (http://www.theheart.org/), a professional news service of WebMD, can be found at www.theheart.org (http://www.theheart.org/), a Web site for cardiovascular healthcare professionals.
Related Links
Resource Centers
Adverse Drug Events Reporting Resource Center (http://www.medscape.com/resource/adverse-drug-events-reporting)
January 29, 2009 (St Louis, Missouri)- Generic drug maker ETHEX Corp, a subsidiary of KV Pharmaceutical, has suspended the manufacture, shipping, and sale of more than 100 products, nearly its entire product line, "as a precautionary measure" following recent recalls of certain specific lots of some of the products, the parent company has announced [1,2].
On the list of suspended drugs are preparations of amlodipine, diltiazem, isosorbide mononitrate, nitroglycerin, and propafenone along with potassium supplements.
"These actions are being taken in cooperation with the previously announced inspection by the FDA of the company’s operations and inventory, which began in December," the company stated in a January 26, 2009 press release.
The earlier recalls had followed the discovery of defects in some product lots, "including oversized tablets delivering higher-than-labeled doses," KV said. It hopes to resume the manufacture and sale of the products after it "reviews its manufacturing and packaging processes."
ETHEX Corp. ETHEX Corporation issues nationwide voluntary recall of products [press release]. January 28, 2009. Available at: http://www.ethex.com/news/pressRelease012809.aspx (http://www.ethex.com/news/pressRelease012809.aspx).
KV Pharmaceutical. KV Pharmaceutical suspends product manufacturing, shipping [press release]. January 26, 2009. Available at: http://www.kvpharma.com/news_center_article.aspx?articleid=278 (http://www.kvpharma.com/news_center_article.aspx?articleid=278).The complete contents of Heartwire (http://www.theheart.org/), a professional news service of WebMD, can be found at www.theheart.org (http://www.theheart.org/), a Web site for cardiovascular healthcare professionals.
Related Links
Resource Centers
Adverse Drug Events Reporting Resource Center (http://www.medscape.com/resource/adverse-drug-events-reporting)